Live Breaking News & Updates on Ilantus technologies

Stay informed with the latest breaking news from Ilantus technologies on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ilantus technologies and stay connected to the pulse of your community

Identity-as-a-Service Market Next Big Thing | Major Giants IBM, Oracle, Capgemini

Identity-as-a-Service Market Next Big Thing | Major Giants IBM, Oracle, Capgemini
iCrowd Newswire
12 May 2021, 16:08 GMT+10
Global Identity-as-a-Service Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Identity-as-a-Service Market. Some of the key players profiled in the study are Ubisecure, Inc., IBM Corporation, Oracle Corporation, Capgemini SE, IDaptive, LLC, CA Technologies (Broadcom Inc.), Microsoft Corporation, Salesforce.com, Inc., Avatier, HCL Technologies Limited, Ilantus Technologies & Okta, Inc..

Australia , Japan , United-states , United-kingdom , Telecom , Cesar , Colombia , Argentina , Brazil , China , South-africa , United-arab-emirates

Why Is Passwordless Authentication Met With Reluctance?

Why Is Passwordless Authentication Met With Reluctance?
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Arunk-singh , Forbes-technology-council , Gartner , Ilantus-technologies , Market-leader , Verizon-data-breach , Technology-council , ஃபோர்ப்ஸ்-தொழில்நுட்பம்-சபை , கார்ட்னர் , சந்தை-தலைவர் , வெரிசோன்-தகவல்கள்-மீறல் , தொழில்நுட்பம்-சபை

Happiest Mind rises on parterning Ilantus Tech

Happiest Minds Technologies rose 1.38% to Rs 549.1 after the IT company said that it has entered into a partnership with Ilantus Technologies to enhance its identity and access management capabilities.The partnership enables Happiest Minds to manage and safeguard an organization's intellectual property from Identity and Access theft while enhancing their risk and regulatory governance landscape.
The partnership with Ilantus is in line with the vision to strengthen the Identity and Access Management within organizations by leveraging technologies such as Artificial Intelligence and Machine learning to have comprehensive visibility to the vulnerabilities arising from Identity and Access exposure from internal and external factors. As a reseller and partner of Ilantus Technologies, Happiest Minds is committed to minimizing the risk factor arising from identity and access thefts while improving customer experience, the company said in a statement.

Ram-mohan , Infrastructure-management-security-services , Happiest-minds-technologies , Ilantus-technologies , Happiest-minds , Access-management , Artificial-intelligence , Infrastructure-management , Security-services , Cloud-identity , Mind-technologies , Big-data-analytics

Happiest Minds Technologies partners with Ilantus Technologies

To deliver next-gen identity and access management capabilitiesHappiest Minds Technologies has entered into a partnership with Ilantus Technologies to enhance its Identity and Access Management
capabilities while supporting customers in their Cybersecurity journey.
The partnership with Ilantus is in line with the vision to strengthen the Identity and Access
Management within organizations by leveraging technologies such as Artificial Intelligence and
Machine learning to have comprehensive visibility to the vulnerabilities arising from Identity and
Access exposure from internal and external factors. As a reseller and partner of Ilantus Technologies,
Happiest Minds Technologies is committed to minimizing the risk factor arising from identity and

Happiest-minds-technologies , Ilantus-technologies , Access-management , Artificial-intelligence , Capital-market , Identity-management , Computer-security , Computing , Computer-network-security , Technology , Sap-netweaver-identity-management

Shares trade with decent gains; breadth strong

Read more about Shares trade with decent gains; breadth strong on Business Standard. The domestic equity benchmarks continued to trade with decent gains in mid-morning trade amid positive global cues. Shares in capital good segment gained for the second day. The Nifty was trading above the 15,250 mark.

India , United-states , White-house , District-of-columbia , Americans , Bharat , Paribas-cardif , Grindwell-norton , Larsen-toubro , Joe-biden , Pandemic-emergency-purchase-programme , European-central-bank

Share Market News: Reliance, Infosys, HPCL, IDBI Bank, AstraZeneca, NMDC, V Mart will be in focus

Share Market News: Reliance, Infosys, HPCL, IDBI Bank, AstraZeneca, NMDC, V Mart will be in focus
Shares of Reliance, Infosys, HPCL, IDBI Bank, AstraZeneca, NMDC, V Mart, Happiest Minds Technologies will be in focus in Friday's trading session
BusinessToday.In | March 12, 2021 | Updated 09:12 IST
Stocks to watch today: Reliance, Infosys, HPCL, IDBI Bank AstraZeneca, NMDC, V Mart
The BSE Sensex and NSE Nifty are likely to open higher on Friday, tracking firm global cues and positive trading at Nifty futures on the Singapore Exchange. Among the individual stocks, shares of Reliance, Infosys, HPCL, IDBI Bank, AstraZeneca, NMDC, V Mart, Happiest Minds Technologies and others will be in focus in Friday's trading session.

Hindustan , India-general , India , United-states , Singapore , Haryana , American , Salil-parekh , Pravin-rao , Anupam-rasayan , Tagrisso-osimertinib , Astrazeneca-pharma